Joint scientific opinion assesses the likelihood of swine-origin influenza A(H3N2) in the EU as low
The joint scientific opinion by three EU agencies assesses and advises on the possible risks posed by influenza A(H3N2)v virus for animal health and the potential implications for animal and human health.
This paper highlights the difficulties that developing countries face in preparing for an influenza pandemic suggesting that approaches applicable in rich countries will not suffice to protect the population since supplies of vaccines and antiviral agents cannot be used.
Investigation of the temporal association of Guillain-Barre´ Syndrome with influenza vaccine and influenza-like illness
This paper details the use of the self-controlled case series method developed by this group and others to investigate the relation of Guillain-Barre syndrome (GBS) with influenza vaccination and influenza-like illness using data from the General Practice Research Database from 1990 to 2005, in the UK.
A Series of publications on oseltamivir resistance in seasonal influenza – A(H1N1-H247Y)
This week has seen a particular flock of article eto the influenza antiviral resistance topic which was first observed in Europe in January 2008 (1,2) but have since been recognised as a global phenomenon.
Trials and Tribulations
Two randomised controlled trials of personal public health measures in Australia and Hong Kong investigating effectiveness of the use of face masks and hand washing in the prevention of secondary cases of influenza-like illness (ILI) or actual influenza in households following diagnosis of a confirmed case of seasonal flu in one family member.
Use of antigens derived from plants to produce recombinant influenza vaccines opens new ways of pandemic influenza vaccine development
Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants.
Impact of universal influenza vaccination policy in Ontario and its implications for vaccination policies in Europe
In 2000 the large Canadian province of Ontario started making seasonal influenza vaccination recommended and available at no cost to all in the province over 6 months of age.
Use of Personal Protective Equipment and risk of symptoms and infection with low pathogenicity Avian Influenza A(H7N3)
This article describes the risks associated with avian influenza (H7N3) infection in humans and its relation with the use of personal protective equipment.
Dose sparing strategy with intradermal influenza vaccination – a possible way of ‘stretching’ vaccine in a pandemic. A trial in patients with solid cancer
This article describes the results of using half-dose influenza immunization in patients with solid cancer and its potential consideration as a dose sparing strategy in the event of an influenza pandemic.